Investors | Analyst Coverage

Investors | Analyst Coverage

The following research coverage is provided by independent third-party analysts. Certain reports may be prepared under commissioned research arrangements with Lytix Biopharma. The views and opinions expressed in these reports are those of the respective analysts and do not necessarily reflect the views of Lytix Biopharma.

DNB Carnegie

Klas Palin

klas.palin@dnbcarnegie.seAccessDNB Carnegie research on Lytix

Redeye Equity Research

Richard Ramanius

richard.ramanius@redeye.seAccessRedeye research on Lytix